Bristol-Myers Squibb’s cancer immunotherapy Opdivo is likely to gain another use in Europe after regulators recommended it after surgery for skin cancer.
Revolutionary CAR-T cell therapies for blood cancer could be on the European market within a few months after they were given the green light by regulators – but they face further price scr
The UK government pledged in May to use artificial intelligence (AI) to prevent more than 20,000 cancer-related deaths a year by 2033, with the prime minister’s plans being welcomed by heal
AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in
